Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Avogaro

Showing results (301-310 of 426) with videos related to

Pageof 43
Sort By:
Diabetes|April 27, 2021
Inhibition of SGLT2 Rescues Bone Marrow Cell Traffic for Vascular Repair: Role of Glucose Control and KetogenesisMattia Albiero, Serena Tedesco, Francesco Ivan Amendolagine, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 19, 2009
Where are we with the management of hypertension? From science to clinical practiceCsaba Farsang, Lisa Naditch-Brule, Angelo Avogaro, et al.
The Journal of Clinical Endocrinology and Metabolism|April 18, 2020
Effectiveness of Dulaglutide in the Real World and in Special Populations of Type 2 Diabetic PatientsMario Luca Morieri, Vera Frison, Mauro Rigato, et al.
Diabetes Care|September 11, 2008
Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factorsCarlo B Giorda, Angelo Avogaro, Marina Maggini, et al.
Acta Ophthalmologica|June 25, 2009
Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucomaGian Paolo Fadini, Claudio Pagano, Ilenia Baesso, et al.
Diabetes|January 14, 2010
Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanismsSaula Vigili de Kreutzenberg, Giulio Ceolotto, Italia Papparella, et al.
Metabolism: Clinical and Experimental|February 29, 2020
Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studiesMario Luca Morieri, Mauro Rigato, Vera Frison, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 9, 2020
Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort StudyXuejun Victor Peng, Rory J McCrimmon, Leah Shepherd, et al.
Pharmacological Research|July 24, 2025
Sex differences in the weight response to GLP-1RA in people with type 2 diabetes. A long-term longitudinal real-world studyMarella Marassi, Andrea Cignarella, Giuseppina T Russo, et al.
Cardiovascular Diabetology|April 4, 2021
PAR-4/Ca<sup>2+</sup>-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetesAlessandra Giannella, Giulio Ceolotto, Claudia Maria Radu, et al.
Pageof 43

Showing results (301-310 of 426) with videos related to

Sort By:
Pageof 43
Diabetes|April 27, 2021
Inhibition of SGLT2 Rescues Bone Marrow Cell Traffic for Vascular Repair: Role of Glucose Control and KetogenesisMattia Albiero, Serena Tedesco, Francesco Ivan Amendolagine, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 19, 2009
Where are we with the management of hypertension? From science to clinical practiceCsaba Farsang, Lisa Naditch-Brule, Angelo Avogaro, et al.
The Journal of Clinical Endocrinology and Metabolism|April 18, 2020
Effectiveness of Dulaglutide in the Real World and in Special Populations of Type 2 Diabetic PatientsMario Luca Morieri, Vera Frison, Mauro Rigato, et al.
Diabetes Care|September 11, 2008
Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factorsCarlo B Giorda, Angelo Avogaro, Marina Maggini, et al.
Acta Ophthalmologica|June 25, 2009
Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucomaGian Paolo Fadini, Claudio Pagano, Ilenia Baesso, et al.
Diabetes|January 14, 2010
Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanismsSaula Vigili de Kreutzenberg, Giulio Ceolotto, Italia Papparella, et al.
Metabolism: Clinical and Experimental|February 29, 2020
Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studiesMario Luca Morieri, Mauro Rigato, Vera Frison, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 9, 2020
Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort StudyXuejun Victor Peng, Rory J McCrimmon, Leah Shepherd, et al.
Pharmacological Research|July 24, 2025
Sex differences in the weight response to GLP-1RA in people with type 2 diabetes. A long-term longitudinal real-world studyMarella Marassi, Andrea Cignarella, Giuseppina T Russo, et al.
Cardiovascular Diabetology|April 4, 2021
PAR-4/Ca<sup>2+</sup>-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetesAlessandra Giannella, Giulio Ceolotto, Claudia Maria Radu, et al.
Pageof 43